Skip to main content
. 2023 Jun 28;7(3):47. doi: 10.3390/vision7030047

Table 1.

Main preoperative results and outcome of chandelier-assisted scleral-buckling-related articles.

Author, Year Study Design Eyes, N. Preop BCVA (Mean ± SD) logMAR Postop BCVA (Mean ± SD) logMAR Technique Operative Time (min) Reattachment Rate N, (%) Complications N. Eyes (%) Final Follow-up, Months (M) or Days (D)
Aras et al. (2012) [17] Prospective study 16 0.2 ± NA 0.5 ± NA 25 G trans-scleral fiber-optic-assisted SB with a torpedo-style light source noncontact WAVS NA 13 (81.3) - GP, 1 (6.25)
- rRD, 2 (12.5)
- Vitreous prolapse at the chandelier insertion site, 4 (25)
13.4 M
Kita et al. (2013) [18] Case Report 1 0.7 0.9 25 G CSB with noncontact WAVS NA 1 (100) None 6 M
Nam et al. (2013) [19] Surgical Technique/Case Series 12 NA NA 25 G CSB and a WAVS contact lens NA NA None NA
Nagpal et al. (2013) [20] Prospective study 10 1.3 ± NA 0.48 ± NA 25 G CSB with contact WAVS NA 9 (90) rRD, 1 (10) 6 M
Gogia et al. (2014) [21] Prospective study 25 1.77 ± 0.28 1.09 ± 0.46 25 G CSB with contact WAVS NA 22/23 (95.6) PPV performed where break was not localized intraoperatively, 2 (8) (no suture?) 24 M
Yokoyama et al. (2017) [22] Case Series 3 for single case Case 1: 0.3
Case 2: 0.2
Case 3: 0.2
for single case Case 1: 0.4
Case 2: 0.8
Case 3: 0.6
27 G twin CSB with contact/noncontact WAVS NA 3(100) None NA
Narayanan et al. (2016) [23] ** Retrospective study CSB
group: 14 **
0.9 ± NA 0.6 ± NA 25 G CSB with noncontact WAVS and Standard SB 77.85 ± 16.37 13 (92.8) - Increase in IOP, 1 (7.1)
- Vitreous prolapse at the chandelier insertion site, 3 (21,4)
- PPV for rRD, 1 (7.1)
186.85 ± 115.63 D(range: 1–11 M)
Imai et al. (2015) [24] Retrospective study 79 0.31 ± 0.65 0.10 ± 0.31 25 G CSB with noncontact WAVS 100.3 ± 31.3 96.2 * - CH, 5 (6.3)
- New retinal break, 1 (1.3)
- Lens touch by the chandelier, 1 (1.3)
- rRD, 6 (7.6)
- Secondary glaucoma, 1 (1.3)
- Cataract, 1 (1.3)
11.8 ± 6.9 M
Seider et al. (2015) [25,26] Retrospective study 12 0.2 ± NA 0.1 ± NA 25 G CSB (11 eyes) and
29 G CSB (1 eye) with contact or noncontact WAVS
117.9 (46–149) 12 (100) - Cataract, 2 (16.7) 234.6 (90–455) D
Tomita et al. (2015) [27] ** Retrospective study WAVS
group: 16 **
0.01 ± 0.24 0.04 ± 0.08 25 G CSB with noncontact WAVS and standard SB 107 ± 41 WAVS group:
15 (93.8)
- ERM, 1 (6.3)
- Corneal epithelial disorder, 1 (6.3)
10.4 M
Haug et al. (2016) [28] Surgical Technique/Case series 7 NA NA 25 G CSB with noncontact WAVS NA 6 (85.7) - PPV for rRD, 1 (14.3) 6 M
Hu et al. (2017) [14] Prospective study 61 NA NA 25 G CSB with contact WAVS NA 57 (93.4) - SH: 2 (3.3)
- rRD, 4 (6.6)
6–27 M
Jo et al. (2017) [29] Retrospective study 17 0.23 ± 0.28 0.20 ± 0.25 25 G CSB with noncontact WAVS 76.8 ± 16.1 16 (94.1) - Vitreous prolapse at the chandelier insertion site, 1 (5.9)
- Increased IOP, 4 (23.5)
- Herpes simplex epithelial keratitis, 1 (5.9)
- PPV for rRD, 1 (5.9)
7.3 ± 3.1 M
range (3–12 M)
Assi et al. (2018) [30] Prospective study 23 1.03 ± 0.83 0.40 ± 0.47 23 G endoilluminator probe with
noncontact WAVS
NA 20 (87) - PVR, 2 (8.7)
- Extension of the buckle for new breaks, 1 (4.3)
12 M
Caporossi et al. (2019) [31] Surgical Technique/Case Series 28 0.8 ± 0.88 0.22 ± 0.25 27 G CSB with noncontact WAVS NA 27 (96.4) - PVR, 1 (3.6) 6.4 M
Nam et al. (2021) [32] Case Report 1 NA NA 27 G endoilluminator probe with contact WAVS NA 1 (100) None 1 M
Cohen et al. (2019) [33] ** Retrospective study 22 0.5 ± NA 0.25 ± 0.30 25 G CSB with noncontact WAVS and Standard SB NA 18 (81.8) - Cataract, 2, (12.5) 6 M
Nossair et al. (2019) [34] Retrospective study 21 1.28 ± 0.41 0.7 ± 0.30 25 G CSB with contact WAVS NA 19 (90.48) - Vitreous prolapse at chandelier insertion site, 4 (19.05)
- Localized SH at drainage site 1 (4.76)
- Choroidal detachment, 1 (4.76)
- Elevated IOP, 2 (9.52)
- ERM, 1 (4.76)
- PVR, 3 (14.29)
- rRD, 2 (9.52%)
24 M
Kita et al. (2019) [35] Retrospective study 18 0.28 ± 0.36 0.07 ± 0.11 3D, 27 G chandelier SB with contact/noncontact WAVS NA 18 (100) - Diplopia, 1 (5.55) 11.3 M
Frisina et al. (2019) [36] Retrospective study 213 0.46 ± 0.76 0.2 ± 0.2 25 G 27 G 29 G CSB with noncontact WAVS 75.5 ± 42 207 (97.19) - rRD 6 (2.81) secondary to PVR (3 eyes) and to a new retinal break (3 eyes)
- Persistent VH2 (0.93)
- MH 1 (0.46)
3 M
Yannuzzi et al. (2020) [37] Case series 3 NA NA 25 G CSB with noncontact WAVS and endolaser illuminated probe NA 3 (100) None 6 M
Agranat et al. (2020) [38] Surgical Technique NA NA NA 3D, 25 G or 27 G modified endoilluminator probe with a silicone guard, with noncontact WAVS NA NA NA NA
Baldwin et al. (2019) [39] ** Retrospective study 16 0.03 ± NA (range 0–0.18) 0.08 ± NA (range 0.02–0.69) 3D, 25 G or 27 G Guarded Light Pipe Endoillumination noncontact WAVS and standard SB - 3D: 90–111; 86–111 (with SRF drainage)
- Standard SB: 94–123; 100–135 (with SRF drainage)
14 (87.5) VH 1 (6.3%) median 11.6 (5.0–23.2)M
Savastano et al. (2020) [40] Retrospective study 20 0.23 ± 0.29 0.77 ± 0.17 27 G CSB with noncontact WAVS and releasable 7.0 vicryl scleral suture NA 19(95) - rRD 1 6 M
La Spina et al. (2021) [41] Retrospective study 107 NA NA 3D, 25 G CSB viewing system with noncontact Mean 41 ± 18 (4) - Displacement of a radial scleral implant 1 (0.9%)
-rRD 5 (6%)
3 M
Albalkini et al. (2022) [42] ** Randomized controlled trial 50 1.32 ± 0.68 0.21 ± 0.17 Chandelier-assisted scleral buckling (CSB) and standard SB 102.48 ± 43.76 18(78.3%) - ERM (44%) 6 M

* Mean values visual acuity values in different scales were converted in logMAR ** In comparative studies, chandelier-assisted scleral buckling versus standard scleral buckling, data from the standard scleral buckling group were not included to unify the table. BCVA: best corrected visual acuity; NA: not available SB: scleral buckling; rRD: recurrent retinal detachment; GP: globe perforation; WAVS: wide-angle viewing systems; PPV: pars plana vitrectomy; CSB: chandelier-assisted scleral buckling; IOP: intraocular pressure; CH: choroidal hemorrhage; ERM: epiretinal membrane; SH: subretinal hemorrhage; PVR: proliferative vitreoretinopathy, VH: vitreous hemorrhage, MH: macular hole; SRF: subretinal fluid.